医院感染控制市场规模、份额和成长分析（按产品、应用、技术、疾病、最终用户和地区）- 产业预测 2025-2032

医院感染控制市场预计将在 2023 年达到 304 亿美元，从 2024 年的 326.2 亿美元成长到 2032 年的 573.2 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.3%。

由于几个关键驱动因素，医院内感染 (HAI) 市场正在经历强劲成长。这一趋势的核心是提高人们对减少医疗环境中交叉感染和感染疾病传播的必要性的认识。政府积极加强感染预防措施正在进一步加速市场扩张。在医院、地区和国家层级实施严格的感染预防标准，有利于在医疗环境中形成安全和卫生的文化。此外，越来越多地采用监测解决方案至关重要，因为它们使医疗保健提供者能够采取主动措施有效地预防和管理医院感染，从而增强整体努力，改善病患安全和健康结果。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

医院感染控制市场规模（按产品和服务）

• 市场概况
• 保护屏障
• 消毒
• 消毒剂
  • 产品
  • 干洗手剂
  • 表面消毒剂
  • 皮肤消毒剂
  • 器械消毒剂
  • 配方
  • 液体消毒剂
  • 消毒纸巾
  • 消毒喷雾
• 消毒剂
• 内视镜再处理产品
• 其他感染控制产品

医院感染控制市场规模（按应用）

• 市场概况
• 疾病检测
• 抗药性检测

医院感染控制市场规模（按技术）

• 市场概况
• 表型分析
• 基因分型方法

医院感染控制市场规模（按疾病）

• 市场概况
• 医院内后天性肺炎
• 血流感染疾病
• 手术部位感染疾病
• 胃肠道感染疾病
• 尿道感染
• 其他的

医院感染控制市场规模（依最终用户划分）

• 市场概况
• 医院及重症监护室
• 门诊手术及诊断中心
• 安养院及妇产中心
• 其他的

医院感染控制市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• 3M Company（United States）
• Becton, Dickinson and Company（BD）（United States）
• bioMerieux SA（France）
• Ecolab Inc.（United States）
• Getinge AB（Sweden）
• Advanced Sterilization Products（ASP）（United States）
• Belimed AG（Switzerland）
• Matachana Group（Spain）
• MMM Group（Germany）
• Reckitt Benckiser Group plc（United Kingdom）
• Metrex Research LLC（United States）
• Miele Group（Germany）
• Pal International（United Kingdom）
• Melag Medizintechnik GmbH & Co. KG（Germany）
• Contec, Inc.（United States）
• MEDALKAN（Greece）
• Systec GmbH（Germany）
• CBMSrl Medical Equipment（Italy）
• Continental Equipment Company（United States）
• BGS Beta-Gamma-Service GmbH & Co. KG（Germany）

结论和建议

Hospital-Acquired Infection Control Market size was valued at USD 30.4 billion in 2023 and is poised to grow from USD 32.62 billion in 2024 to USD 57.32 billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

The Hospital Acquired Infections (HAIs) market is experiencing robust growth due to several critical drivers. An increased awareness of the need to reduce cross infections and the ongoing prevalence of infectious diseases in healthcare settings are central to this trend. Supportive government initiatives that advocate for enhanced infection control practices further amplify market expansion. The implementation of stringent infection prevention standards at hospital, regional, and national levels fosters a culture of safety and hygiene within medical environments. Additionally, the rising adoption of monitoring solutions is pivotal, as it empowers healthcare providers to take proactive steps in effectively preventing and managing HAIs, thereby reinforcing the overall commitment to improving patient safety and health outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Hospital-Acquired Infection Control market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Hospital-Acquired Infection Control Market Segments Analysis

Global Hospital-Acquired Infection Control Market is segmented by Product, Application, Technology, Disease, End User and region. Based on Product, the market is segmented into Protective Barrier, Sterilization, Disinfectants, Disinfectors, Endoscope Reprocessing Products and Other Infection Control Products. Based on Application, the market is segmented into Disease Testing and Drug-Resistance Testing. Based on Technology, the market is segmented into Phenotypic Methods and Genotypic Methods. Based on Disease, the market is segmented into Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection and Others. Based on End User, the market is segmented into Hospitals & ICUs, Ambulatory Surgical & Diagnostic Centers, Nursing Homes & Maternity Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Hospital-Acquired Infection Control Market

The Hospital-Acquired Infection Control market is significantly driven by the notable increase in the number of surgical procedures performed globally in recent years. According to the World Health Organization's 2022 data, approximately 330 million major surgeries are conducted each year around the world. This surge can be attributed to various factors, including the rising incidence of obesity and other lifestyle-related health conditions, which often require surgical solutions for effective treatment and management. As more surgeries are performed, the demand for robust infection control measures in hospitals continues to escalate, underscoring the importance of enhancing patient safety and care standards.

Restraints in the Hospital-Acquired Infection Control Market

The Hospital-Acquired Infection Control market faces significant restraints primarily because healthcare providers frequently choose to reprocess reusable medical devices to save costs and minimize waste. These devices include various instruments, such as surgical forceps, endoscopes, and stethoscopes. However, this practice raises ongoing concerns about the safety and effectiveness of these reprocessed instruments. As the apprehension surrounding potential risks to patient safety continues to grow, it complicates the market dynamics for infection control solutions, as both healthcare facilities and patients prioritize safer alternatives to ensure better health outcomes and reduce the incidence of hospital-acquired infections.

Market Trends of the Hospital-Acquired Infection Control Market

The Hospital-Acquired Infection Control market is witnessing a significant trend with the reintroduction of ethylene oxide sterilization, a key method known for its efficiency in sterilizing temperature-sensitive medical instruments. This resurgence is driven by the increasing demand for effective sterilization methods amid rising hospital-acquired infections, combined with a push for improved infection control protocols. However, the market is also experiencing scrutiny over potential health risks associated with ethylene oxide exposure, prompting regulatory bodies to assess safety standards. As hospitals seek to balance efficacy and safety, advancements in ethylene oxide technology and alternative sterilization methods are anticipated to shape the future dynamics of the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Hospital-Acquired Infection Control Market Size by Product & Services & CAGR (2025-2032)

• Market Overview
• Protective Barrier
• Sterilization
• Disinfectants
  • Product
  • Hand Disinfectants
  • Surface Disinfectants
  • Skin Disinfectants
  • Instrument Disinfectants
  • Formulation
  • Liquid Disinfectants
  • Disinfectant Wipes
  • Disinfectant Sprays
• Disinfectors
• Endoscope Reprocessing Products
• Other Infection Control Products

Global Hospital-Acquired Infection Control Market Size by Application & CAGR (2025-2032)

• Market Overview
• Disease Testing
• Drug-Resistance Testing

Global Hospital-Acquired Infection Control Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Phenotypic Methods
• Genotypic Methods

Global Hospital-Acquired Infection Control Market Size by Disease & CAGR (2025-2032)

• Market Overview
• Hospital Acquired Pneumonia
• Bloodstream Infections
• Surgical Site Infections
• Gastrointestinal Infections
• Urinary Tract Infection
• Others

Global Hospital-Acquired Infection Control Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & ICUs
• Ambulatory Surgical & Diagnostic Centers
• Nursing Homes & Maternity Centers
• Others

Global Hospital-Acquired Infection Control Market Size & CAGR (2025-2032)

• North America (Product & Services, Application, Technology, Disease, End User)
  • US
  • Canada
• Europe (Product & Services, Application, Technology, Disease, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Application, Technology, Disease, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Application, Technology, Disease, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Application, Technology, Disease, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• 3M Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ecolab Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Sterilization Products (ASP) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Belimed AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Matachana Group (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MMM Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metrex Research LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miele Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pal International (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Melag Medizintechnik GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Contec, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEDALKAN (Greece)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Systec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C.B.M. S.r.l. Medical Equipment (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Continental Equipment Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGS Beta-Gamma-Service GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations